59 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34949747 | Immune-Enhancing Effects of Crude Polysaccharides from Korean Ginseng Berries on Spleens of Mice with Cyclophosphamide-Induced Immunosuppression. | 2022 Feb 28 | 1 |
2 | 34128029 | Alhagi honey polysaccharides attenuate intestinal injury and immune suppression in cyclophosphamide-induced mice. | 2021 Aug 2 | 1 |
3 | 34840584 | The Immunomodulatory Effects of Phellodendri Cortex Polysaccharides on Cyclophosphamide-Induced Immunosuppression in Mice. | 2021 | 1 |
4 | 32306006 | [Effect of Fei-Liu-Ping ointment combined with cyclophosphamide on lung cancer cell proliferation and acidic microenvironment]. | 2020 Apr 18 | 1 |
5 | 32475918 | Characterization and Immunological Activities of Polysaccharides from Polygonatum sibiricum. | 2020 | 2 |
6 | 33266362 | Immunostimulatory Effects of Live Lactobacillus sakei K040706 on the CYP-Induced Immunosuppression Mouse Model. | 2020 Nov 22 | 1 |
7 | 30268651 | Xinjiang herbal tea exerts immunomodulatory activity via TLR2/4-mediated MAPK signaling pathways in RAW264.7 cells and prevents cyclophosphamide-induced immunosuppression in mice. | 2019 Jan 10 | 1 |
8 | 28939510 | Characterization and protective effect of Polygonatum sibiricum polysaccharide against cyclophosphamide-induced immunosuppression in Balb/c mice. | 2018 Feb | 1 |
9 | 25708328 | Chronodependent effect of interleukin-2 on mouse spleen cells in the model of cyclophosphamide immunosuppression. | 2015 Feb | 3 |
10 | 25785030 | Effect of Chuanminshen violaceum polysaccharides and its sulfated derivatives on immunosuppression induced by cyclophosphamide in mice. | 2015 | 1 |
11 | 23659474 | Improving the in vivo persistence, distribution and function of cytotoxic T lymphocytes by inhibiting the tumor immunosuppressive microenvironment. | 2013 Jul | 1 |
12 | 21649551 | Effect of millimeter waves and cyclophosphamide on cytokine regulation. | 2012 Feb | 1 |
13 | 22667143 | [Study on extraction and immune regulation of polysaccharides from Marsdenia tenacissima]. | 2012 Feb | 1 |
14 | 22814394 | SJSZ glycoprotein (38 kDa) modulates expression of IL-2, IL-12, and IFN-γ in cyclophosphamide-induced Balb/c. | 2012 Dec | 1 |
15 | 23000689 | Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model. | 2012 Nov | 2 |
16 | 21279551 | Effect of zymosan on antioxidant and immune function of S180 tumor-bearing mice. | 2011 Jul | 1 |
17 | 19946662 | Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice. | 2010 Feb | 1 |
18 | 18853118 | Effect of Radix isatidis polysaccharides on immunological function and expression of immune related cytokines in mice. | 2008 Sep | 2 |
19 | 17255288 | Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration. | 2007 Jan 15 | 1 |
20 | 10607705 | Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. | 2000 Jan 1 | 1 |
21 | 10089919 | Paclitaxel vs cyclophosphamide in peripheral blood stem cell mobilization: comparative studies in a murine model. | 1999 Mar | 1 |
22 | 10464704 | Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide. | 1999 Jun | 1 |
23 | 9174132 | Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells. | 1997 May | 1 |
24 | 9222281 | Priming of the antitumor response promotes efficacy of interleukin-2 therapy. | 1997 Jun | 1 |
25 | 8706342 | Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes. | 1996 Aug | 1 |
26 | 8933279 | Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates. | 1996 Oct | 2 |
27 | 7600560 | The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanoma. | 1995 May | 1 |
28 | 7622294 | Correlation between the sensitivity or resistance to IL-2 and the response to cyclophosphamide of 4 tumors transplantable in the same murine host. | 1995 Jul 17 | 1 |
29 | 7759164 | Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma. | 1995 May 16 | 1 |
30 | 7860617 | Interleukin-2 gene therapy of residual EL-4 leukaemia potentiates the effect of cyclophosphamide pretreatment. | 1995 | 2 |
31 | 7804526 | Delivery of cytokines by liposomes. II. Interleukin-2 encapsulated in long-circulating sterically stabilized liposomes: immunomodulatory and anti-tumor activity in mice. | 1994 Aug | 1 |
32 | 7974716 | The inhibitory effect of cyclophosphamide-induced MAC-1+ natural suppressor cells on IL-2 and IL-4 utilization in MLR. | 1994 Nov 27 | 1 |
33 | 8010605 | Melatonin restores immunodepression in aged and cyclophosphamide-treated mice. | 1994 May 31 | 1 |
34 | 8168119 | Chemotherapy-induced modulation of natural killer and lymphokine-activated killer cell activity in euthymic and athymic mice. | 1994 Apr | 2 |
35 | 8425189 | Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression. | 1993 Feb 1 | 1 |
36 | 1361881 | Tumor-specific chemoimmunotherapy of murine fibrosarcoma using tumor-specific transplantation antigen, cyclophosphamide, and interleukin-2. | 1992 | 1 |
37 | 1534792 | Melatonin as immunomodulator in immunodeficient mice. | 1992 Mar-Apr | 1 |
38 | 1760819 | Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysis. | 1991 | 3 |
39 | 1835471 | Interleukin-2 enhances the translocation of Escherichia coli from the intestines to other organs. | 1991 Dec | 4 |
40 | 1991327 | Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice. | 1991 Mar | 1 |
41 | 1718146 | Immune enhancement of a polysaccharides peptides isolated from Coriolus versicolor. | 1990 Nov | 1 |
42 | 2389941 | [Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy]. | 1990 Aug | 1 |
43 | 2666309 | Patterns of IL-2 production and utilization in mice heavily infected with Mycobacterium bovis BCG reflect the phase of protective immunity being expressed. | 1989 Jun | 1 |
44 | 2785003 | Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide. IL-2 can facilitate or inhibit tumor growth depending on the sequence of treatment and the tumor type. | 1989 | 4 |
45 | 2895062 | Lethal vaccinia infection in cyclophosphamide-suppressed mice is associated with decreased expression of Thy-1, Lyt-2 and L3T4 and diminished IL-2 production in surviving T cells. | 1988 Mar | 1 |
46 | 3257159 | Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors. | 1988 Jan 1 | 4 |
47 | 3260132 | Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide. | 1988 | 8 |
48 | 3264714 | Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model. | 1988 Oct | 1 |
49 | 2444243 | Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2. | 1987 Aug | 1 |
50 | 2949833 | In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. | 1987 | 3 |